In this report, the EMEA Measle Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Measle Vaccine for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Measle Vaccine market competition by top manufacturers/players, with Measle Vaccine sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
GSK
Biovac
McKesson Medical
...
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Inactivated Vaccine
Attenuated Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Scientific Research
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
EMEA (Europe, Middle East and Africa) Measle Vaccine Market Report 2017
1 Measle Vaccine Overview
1.1 Product Overview and Scope of Measle Vaccine
1.2 Classification of Measle Vaccine
1.2.1 EMEA Measle Vaccine Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Measle Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Inactivated Vaccine
1.2.4 Attenuated Vaccine
1.3 EMEA Measle Vaccine Market by Application/End Users
1.3.1 EMEA Measle Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 EMEA Measle Vaccine Market by Region
1.4.1 EMEA Measle Vaccine Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Measle Vaccine (2012-2022)
1.5.1 EMEA Measle Vaccine Sales and Growth Rate (2012-2022)
1.5.2 EMEA Measle Vaccine Revenue and Growth Rate (2012-2022)
2 EMEA Measle Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Measle Vaccine Market Competition by Players/Manufacturers
2.1.1 EMEA Measle Vaccine Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Measle Vaccine Revenue and Share by Players (2012-2017)
2.1.3 EMEA Measle Vaccine Sale Price by Players (2012-2017)
2.2 EMEA Measle Vaccine (Volume and Value) by Type/Product Category
2.2.1 EMEA Measle Vaccine Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Measle Vaccine Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Measle Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Measle Vaccine (Volume) by Application
2.4 EMEA Measle Vaccine (Volume and Value) by Region
2.4.1 EMEA Measle Vaccine Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Measle Vaccine Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Measle Vaccine Sales Price by Region (2012-2017)
3 Europe Measle Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Measle Vaccine Sales and Value (2012-2017)
3.1.1 Europe Measle Vaccine Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Measle Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Measle Vaccine Sales and Market Share by Type
3.3 Europe Measle Vaccine Sales and Market Share by Application
3.4 Europe Measle Vaccine Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Measle Vaccine Sales Volume by Countries (2012-2017)
3.4.2 Europe Measle Vaccine Revenue by Countries (2012-2017)
3.4.3 Germany Measle Vaccine Sales and Growth Rate (2012-2017)
3.4.4 France Measle Vaccine Sales and Growth Rate (2012-2017)
3.4.5 UK Measle Vaccine Sales and Growth Rate (2012-2017)
3.4.6 Russia Measle Vaccine Sales and Growth Rate (2012-2017)
3.4.7 Italy Measle Vaccine Sales and Growth Rate (2012-2017)
3.4.8 Benelux Measle Vaccine Sales and Growth Rate (2012-2017)
4 Middle East Measle Vaccine (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Measle Vaccine Sales and Value (2012-2017)
4.1.1 Middle East Measle Vaccine Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Measle Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Measle Vaccine Sales and Market Share by Type
4.3 Middle East Measle Vaccine Sales and Market Share by Application
4.4 Middle East Measle Vaccine Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Measle Vaccine Sales Volume by Countries (2012-2017)
4.4.2 Middle East Measle Vaccine Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Measle Vaccine Sales and Growth Rate (2012-2017)
4.4.4 Israel Measle Vaccine Sales and Growth Rate (2012-2017)
4.4.5 UAE Measle Vaccine Sales and Growth Rate (2012-2017)
4.4.6 Iran Measle Vaccine Sales and Growth Rate (2012-2017)
5 Africa Measle Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Measle Vaccine Sales and Value (2012-2017)
5.1.1 Africa Measle Vaccine Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Measle Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Measle Vaccine Sales and Market Share by Type
5.3 Africa Measle Vaccine Sales and Market Share by Application
5.4 Africa Measle Vaccine Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Measle Vaccine Sales Volume by Countries (2012-2017)
5.4.2 Africa Measle Vaccine Revenue by Countries (2012-2017)
5.4.3 South Africa Measle Vaccine Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Measle Vaccine Sales and Growth Rate (2012-2017)
5.4.5 Egypt Measle Vaccine Sales and Growth Rate (2012-2017)
5.4.6 Algeria Measle Vaccine Sales and Growth Rate (2012-2017)
6 EMEA Measle Vaccine Manufacturers/Players Profiles and Sales Data
6.1 GSK
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Measle Vaccine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GSK Measle Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Biovac
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Measle Vaccine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Biovac Measle Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 McKesson Medical
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Measle Vaccine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 McKesson Medical Measle Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
...
7 Measle Vaccine Manufacturing Cost Analysis
7.1 Measle Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Measle Vaccine
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Measle Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Measle Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Measle Vaccine Market Forecast (2017-2022)
11.1 EMEA Measle Vaccine Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Measle Vaccine Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Measle Vaccine Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Measle Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Measle Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Measle Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Measle Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Measle Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Measle Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Measle Vaccine Sales Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Measle Vaccine
Figure EMEA Measle Vaccine Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Measle Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Inactivated Vaccine Product Picture
Figure Attenuated Vaccine Product Picture
Figure EMEA Measle Vaccine Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Measle Vaccine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Measle Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Measle Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Measle Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Measle Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Measle Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Measle Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Measle Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Measle Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Measle Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Measle Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Measle Vaccine Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Measle Vaccine Sales Share by Players (2012-2017)
Figure 2016 Measle Vaccine Sales Share by Players
Figure 2017 Measle Vaccine Sales Share by Players
Figure EMEA Measle Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Measle Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Measle Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Measle Vaccine Revenue Share by Players
Table 2017 EMEA Measle Vaccine Revenue Share by Players
Table EMEA Measle Vaccine Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Measle Vaccine Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Measle Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Measle Vaccine by Type (2012-2017)
Figure EMEA Measle Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Measle Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Measle Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Measle Vaccine by Type in 2016
Table EMEA Measle Vaccine Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Measle Vaccine Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Measle Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Measle Vaccine by Application (2012-2017)
Figure EMEA Measle Vaccine Sales Market Share by Application in 2016
Table EMEA Measle Vaccine Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Measle Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Measle Vaccine by Region (2012-2017)
Figure EMEA Measle Vaccine Sales Market Share in 2016
Table EMEA Measle Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Measle Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Measle Vaccine by Region (2012-2017)
Figure EMEA Measle Vaccine Revenue Market Share Regions in 2016
Table EMEA Measle Vaccine Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Measle Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Measle Vaccine Sales (K Pcs) by Type (2012-2017)
Table Europe Measle Vaccine Market Share by Type (2012-2017)
Figure Europe Measle Vaccine Market Share by Type in 2016
Table Europe Measle Vaccine Sales (K Pcs) by Application (2012-2017)
Table Europe Measle Vaccine Market Share by Application (2012-2017)
Figure Europe Measle Vaccine Market Share by Application in 2016
Table Europe Measle Vaccine Sales (K Pcs) by Countries (2012-2017)
Table Europe Measle Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Measle Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Measle Vaccine Sales Market Share by Countries in 2016
Table Europe Measle Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Measle Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Measle Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Measle Vaccine Revenue Market Share by Countries in 2016
Figure Germany Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Measle Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Measle Vaccine Sales (K Pcs) by Type (2012-2017)
Table Middle East Measle Vaccine Market Share by Type (2012-2017)
Figure Middle East Measle Vaccine Market Share by Type (2012-2017)
Table Middle East Measle Vaccine Sales (K Pcs) by Applications (2012-2017)
Table Middle East Measle Vaccine Market Share by Applications (2012-2017)
Figure Middle East Measle Vaccine Sales Market Share by Application in 2016
Table Middle East Measle Vaccine Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Measle Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Measle Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Measle Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Measle Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Measle Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Measle Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Measle Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Measle Vaccine Sales (K Pcs) by Type (2012-2017)
Table Africa Measle Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Measle Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Measle Vaccine Sales Market Share by Type in 2016
Table Africa Measle Vaccine Sales (K Pcs) by Application (2012-2017)
Table Africa Measle Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Measle Vaccine Sales Market Share by Application (2012-2017)
Table Africa Measle Vaccine Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Measle Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Measle Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Measle Vaccine Sales Market Share by Countries in 2016
Table Africa Measle Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Measle Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Measle Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Measle Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table GSK Measle Vaccine Basic Information List
Table GSK Measle Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure GSK Measle Vaccine Sales Market Share in EMEA (2012-2017)
Figure GSK Measle Vaccine Revenue Market Share in EMEA (2012-2017)
Table Biovac Measle Vaccine Basic Information List
Table Biovac Measle Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biovac Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biovac Measle Vaccine Sales Market Share in EMEA (2012-2017)
Figure Biovac Measle Vaccine Revenue Market Share in EMEA (2012-2017)
Table McKesson Medical Measle Vaccine Basic Information List
Table McKesson Medical Measle Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure McKesson Medical Measle Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure McKesson Medical Measle Vaccine Sales Market Share in EMEA (2012-2017)
Figure McKesson Medical Measle Vaccine Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Measle Vaccine
Figure Manufacturing Process Analysis of Measle Vaccine
Figure Measle Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Measle Vaccine Major Manufacturers in 2016
Table Major Buyers of Measle Vaccine
Table Distributors/Traders List
Figure EMEA Measle Vaccine Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Measle Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Measle Vaccine Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Measle Vaccine Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Measle Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Measle Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Measle Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Measle Vaccine Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Measle Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Measle Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Measle Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Measle Vaccine Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Measle Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Measle Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Measle Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Measle Vaccine Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Measle Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Measle Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Measle Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Measle Vaccine Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Measle Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Measle Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Measle Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
